Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG
Active substance: tenecteplase
tenecteplase
Centralised EU authorisationWithdrawn
Marketing holder: Boehringer Ingelheim International GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 4 |
|
| US 3 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4398-7789-80d2-09b4e3064258,01a120c3-a1a8-7ea5-b77b-cb1c7d3fa52e,01a120c3-e9f5-7c12-a72d-b571ecc5f5c3,01a120c5-91d1-7a46-8aba-f6b2df7e05dd;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-306f-737f-8fe3-1bf4d6c19752,01a12098-bc18-726b-ac11-facad13271f3,01a12098-bc1d-782f-b6c8-07216e395072;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000307
- Registration status
- Withdrawn
- ATC code
- B01AD
Sources
- product · EMA · EMEA/H/C/000307 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000307 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000307 · Verified 2026-10-09